NCT06360991View on ClinicalTrials.gov

DBS for Treatment-resistant Obsessive-compulsive Disorder

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 20, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Obsessive-Compulsive Disorder (OCD)
Interventions
DEVICE

Deep brain stimulation (DBS)

The DBS lead is stereotactically introduced into the target in the brain (vALIC, BNST, amSTN, VC/VS, or NAc) and fixed to the skull; the lead is then connected to a neurostimulator implanted subcutaneously in the subclavicular region.

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT06360991 - DBS for Treatment-resistant Obsessive-compulsive Disorder | Biotech Hunter | Biotech Hunter